NASDAQ
10.11.26 | 21:59
31,600 US-Dollar
-0,19 % -0,060
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SANARA MEDTECH Aktie jetzt für 0€ handeln | |||||
| 16.10. | Sanara MedTech/MiMedx deal spread widens on FTC second request | 4 | Seeking Alpha | ||
| 16.10. | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.08. | Sanara MedTech Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.08. | Sanara MedTech GAAP EPS of -$0.05 misses by $0.02, revenue of $28.14M misses by $0.81M | 1 | Seeking Alpha | ||
| 11.08. | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | 357 | GlobeNewswire (Europe) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| 30.07. | MiMedx to acquire Sanara MedTech for $350M | 2 | MassDevice | ||
| 30.07. | MIMEDX To Acquire Sanara MedTech In $350 Million Transaction | 2 | pulse2.com | ||
| 30.07. | H.C. Wainwright cuts Sanara MedTech stock rating on acquisition deal | 1 | Investing.com | ||
| 29.07. | MiMedx agrees to buy Sanara MedTech for $35 a share | 3 | Seeking Alpha | ||
| 29.07. | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.07. | MIMEDX übernimmt Sanara MedTech für 350 Millionen US-Dollar | 5 | Investing.com Deutsch | ||
| 29.07. | MiMedx Group, Inc.: MIMEDX to Acquire Sanara MedTech | 1.078 | GlobeNewswire (Europe) | Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX's Strategic Priority to Expand Surgical Footprint, Nearly Doubling... ► Artikel lesen | |
| 17.06. | Sanara MedTech: Freedom Broker startet Coverage mit Kaufempfehlung und Kursziel 35 $ | 2 | Investing.com Deutsch | ||
| 17.06. | Freedom Broker initiates Sanara MedTech stock with buy rating, $35 target | 1 | Investing.com | ||
| 04.06. | Sanara MedTech Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 11.05. | Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) | 377 | GlobeNewswire (Europe) | Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara... ► Artikel lesen | |
| 23.01. | Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance | 283 | GlobeNewswire (Europe) | FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| 10.12.25 | Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic | 342 | GlobeNewswire (Europe) | Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic's granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara... ► Artikel lesen | |
| 11.11.25 | Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business | 319 | GlobeNewswire (Europe) | Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us")... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP | 14,550 | -0,07 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| GENEDX | 54,93 | +0,18 % | Why GeneDx Holdings Stock Just Dropped 16.6% | ||
| BRIGHTSPRING HEALTH SERVICES | 72,51 | +0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 112,12 | 0,00 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target | ||
| BASEL MEDICAL GROUP | 1,900 | -1,55 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS | 53,63 | +0,30 % | Ihre wichtigsten Termine: Frische Zahlen von: Uber, Novo Nordisk, Qualcomm, Allstate, McDonald's und BMW | © Foto: Steffen Trumpf/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0200021014... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 1,850 | 0,00 % | Autonomix Medical, Inc.: Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology | ||
| PROGYNY | 36,450 | +0,05 % | Progyny, Inc. - 10-Q, Quarterly Report | ||
| SIEMENS HEALTHINEERS | 43,140 | +0,47 % | EQS-AFR: Siemens Healthineers AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Siemens Healthineers AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Siemens Healthineers AG: Vorabbekanntmachung... ► Artikel lesen | |
| ADAPTHEALTH | 7,720 | 0,00 % | AdaptHealth auf der UBS Global Healthcare Conference: Trendwende bei Kaiser Permanente leitet Konsolidierungsphase ein | ||
| PROCEPT BIOROBOTICS | 23,070 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| STARLING ONCOLOGY INSTITUTE | 4,320 | -0,46 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| GMR SOLUTIONS | 10,985 | 0,00 % | GMR Solutions Q3 2026 slides: profit surges despite cost headwinds | ||
| KESTRA MEDICAL TECHNOLOGIES | 29,550 | 0,00 % | Kestra Medical auf Wolfe Research-Konferenz: Starkes Marktwachstum und Ausbau der Produktpipeline | ||
| ALIGNMENT HEALTHCARE | 7,685 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
SANARA MEDTECH INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,19 % bei einem Aktienkurs von 31,600 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANARA MEDTECH INC finden Sie auf Wallstreet Online.